Sunil Healthcare Limited (BOM:537253)

India flag India · Delayed Price · Currency is INR
69.00
-1.00 (-1.43%)
At close: Feb 12, 2026
Market Cap697.32M -15.0%
Revenue (ttm)892.01M +6.8%
Net Income28.53M
EPS2.78
Shares Out10.25M
PE Ratio24.47
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6
Average Volume627
Open69.65
Previous Close70.00
Day's Range69.00 - 69.65
52-Week Range60.55 - 88.70
Beta-0.26
RSI50.16
Earnings DateFeb 6, 2026

About Sunil Healthcare

Sunil Healthcare Limited engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally. Its products include EHG, BSE/TSE free, pearl, liquid fill, preservative free, stick free, flavored, SLS free, natural color, non-AZO, gelatin, HPMC/vegetable, and pullulan capsules. The company also provides ayurvedic products, such as haldi, ginger, vasaka, trifala, guduchi, salaki, punarvana, shatavari, hadjod, hingwastak, mulethi, arjuna, ashwagandha, and guggul ... [Read more]

Industry Miscellaneous Chemical Products
Founded 1973
Employees 161
Stock Exchange Bombay Stock Exchange
Ticker Symbol 537253
Full Company Profile

Financial Performance

In fiscal year 2025, Sunil Healthcare's revenue was 834.21 million, a decrease of -7.51% compared to the previous year's 901.92 million. Losses were -14.17 million, -20.79% less than in 2024.

Financial Statements